Next Generation News and Research

RSS

Researchers develop new chemical-only process for creating customized mRNA vaccines

Researchers at Nagoya University in Japan have developed a new chemical-only process that may represent an important breakthrough in creating customized mRNA vaccines for a variety of diseases and allow for the inexpensive preparation of mRNA in large quantities.

8 Jun 2022

Researchers plan to commence a clinical trial on new COVID-19 inactivated vaccine

A medical research team from the University of Hong Kong (HKU) will start a large-scale clinical trial on a new COVID-19 inactivated vaccine (Omicron variant) developed by China National Biotec Group (Sinopharm).

8 Jun 2022

Scientists provide crucial insights into the roles of inflammation and oxidative stress in certain cancers

Rampant inflammation has long been linked to cancer but exactly how it pushes healthy cells to transform into malignant ones has remained a mystery.

7 Jun 2022

Oral pill taken once a day improves outcomes of patients with myelofibrosis

Momelotinib, an oral pill taken once a day, significantly improved outcomes of patients treated for myelofibrosis (MF), a rare but fatal bone marrow cancer, researchers reported June 7.

7 Jun 2022

Promising results of combination treatment for acute myeloid leukemia to be presented at ASCO 2022

On Tuesday, June 7, Eunice Wang, MD, Chief of Leukemia at Roswell Park Comprehensive Cancer Center, will present the long-term results of a phase 2 clinical trial combining crenolanib, a second-generation FLT3 inhibitor, with standard intensive chemotherapy for treatment of adults with newly diagnosed FLT3-mutant acute myeloid leukemia (AML).

6 Jun 2022

Three-drug therapy with autologous stem cell transplant improves progression-free survival for multiple myeloma patients

Patients with multiple myeloma who have been treated with a three-drug combination therapy have a growing number of choices for subsequent treatment. Results of a new study led by researchers at Dana-Farber Cancer Institute can help patients and their physicians weigh benefits and risks of each option.

6 Jun 2022

Fecal Microbiota Transplantation found to be an optimal cost-effective treatment for recurrent C. difficile infection

Research recently published in Clinical Infectious Diseases from the University of Minnesota Medical School has found that Fecal Microbiota Transplantation, or FMT, is an optimal cost-effective treatment for first recurrent Clostridioides difficile infection, or CDI or C-Diff.

3 Jun 2022

New compound shows promise to kill a range of hard-to-treat cancer types

A compound, developed by a team including scientists from The University of Texas Health Science Center at San Antonio, kills a range of hard-to-treat cancer types in petri dishes and animal models by targeting a previously unexploited vulnerability, a new study reports.

2 Jun 2022

Dispositional mindfulness can reduce and protect athletes from stress

Just like the saying, 'when the going gets tough, the tough get going', elite athletes are known for their stamina and determination. But nearly a third of professional athletes struggle with mental health.

2 Jun 2022

New SOL-INCA-AD grant extends the initial study to examine cognitive aging among Latinos

Researchers at University of California San Diego School of Medicine have received a $24.5 million grant from the National Institutes of Health (NIH)/National Institute on Aging (NIA) to continue the Study of Latinos-Investigation of Neurocognitive Aging (SOL-INCA), a 12-year assessment of cognitive and brain aging and impairment among aging Latinos.

1 Jun 2022

Stem cell model could provide insights into biological mechanisms that underlie neuropsychiatric disorders

Researchers from the Icahn School of Medicine at Mount Sinai have applied a novel stem cell model to map disease risk variants in human neurons, which could help provide insights into the biological mechanisms that underlie neuropsychiatric disorders such as autism and schizophrenia.

1 Jun 2022

Substances touted to improve athletic performance and high fat diet fuel pancreatic cancer’s development

Researchers at the University of Michigan Rogel Cancer Center have found a cell nuclear receptor activated by high fat diets and synthetic substances in unregulated athletic performance enhancers fuels the progression of precancerous pancreas lesions into pancreatic cancer.

1 Jun 2022

Combination bNAb therapy may offer a future alternative to daily ART for people living with HIV

Individuals with HIV who began taking antiretroviral therapy (ART) in the early stages of infection achieved a lengthy period of HIV suppression without ART after receiving two broadly neutralizing anti-HIV antibodies (bNAbs), according to a small study published today in the journal Nature.

1 Jun 2022

seqWell and Element Biosciences partner to demonstrate sequencing performance of multiplexed plexWell technology with the AVITI System

seqWell today announced a partnership with Element Biosciences Inc., developer of the Element AVITI™ System.

From Element Biosciences 1 Jun 2022

Liver4Life research team treated damaged liver in a machine and then implanted the recovered organ

The multidisciplinary Zurich research team Liver4Life has succeeded in doing something during a treatment attempt that had never been achieved in the history of medicine until now: it treated an originally damaged human liver in a machine for three days outside a body and then implanted the recovered organ into a cancer patient.

31 May 2022

Next Generation News and Research

Researchers develop new chemical-only process for creating customized mRNA vaccines

Researchers plan to commence a clinical trial on new COVID-19 inactivated vaccine

Scientists provide crucial insights into the roles of inflammation and oxidative stress in certain cancers

Oral pill taken once a day improves outcomes of patients with myelofibrosis

Promising results of combination treatment for acute myeloid leukemia to be presented at ASCO 2022

Three-drug therapy with autologous stem cell transplant improves progression-free survival for multiple myeloma patients

Fecal Microbiota Transplantation found to be an optimal cost-effective treatment for recurrent C. difficile infection

New compound shows promise to kill a range of hard-to-treat cancer types

Dispositional mindfulness can reduce and protect athletes from stress

New SOL-INCA-AD grant extends the initial study to examine cognitive aging among Latinos

Stem cell model could provide insights into biological mechanisms that underlie neuropsychiatric disorders

Substances touted to improve athletic performance and high fat diet fuel pancreatic cancer’s development

Combination bNAb therapy may offer a future alternative to daily ART for people living with HIV

seqWell and Element Biosciences partner to demonstrate sequencing performance of multiplexed plexWell technology with the AVITI System

Liver4Life research team treated damaged liver in a machine and then implanted the recovered organ

Robust and highly multiplexed assay for identification of SARS-CoV-2 variants

HIV research enables knowledge transfer for improved COVID-19 response

Study shows how stress has a major impact on the immune system's ability to fight infections

Researchers report the case of a non-vaccinated patient coinfected with SARS-CoV-2 Omicron BA.1 and BA.2

Mapping the Types and Traits of Immune Cells

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News